Glucocorticoids and treatment of prostate cancer: A preclinical and clinical review

被引:56
作者
Fakih, M
Johnson, CS
Trump, DL
机构
[1] Univ Pittsburgh, Pittsburgh Canc Inst, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Sch Med, Dept Med, Div Hematol Oncol & Pharmacol, Pittsburgh, PA 15213 USA
关键词
D O I
10.1016/S0090-4295(02)01741-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:553 / 561
页数:9
相关论文
共 53 条
  • [1] Arai Y, 2000, INT J HEMATOL, V71, P340
  • [2] Barrack ER, 1997, PROSTATE, V31, P61
  • [3] Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: Recommendations from the prostate-specific antigen working group
    Bubley, GJ
    Carducci, M
    Dahut, W
    Dawson, N
    Daliani, D
    Eisenberger, M
    Figg, WD
    Freidlin, B
    Halabi, S
    Hudes, G
    Hussain, M
    Kaplan, R
    Myers, C
    Oh, W
    Petrylak, DP
    Reed, E
    Roth, B
    Sartor, O
    Scher, H
    Simons, J
    Sinibaldi, V
    Small, EJ
    Smith, MR
    Trump, DL
    Vollmer, R
    Wilding, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (11) : 3461 - 3467
  • [4] Carollo M, 1998, ONCOL RES, V10, P245
  • [5] Chang CY, 2001, CANCER RES, V61, P8712
  • [6] Androgen and glucocorticoid receptor heterodimer formation - A possible mechanism for mutual inhibition of transcriptional activity
    Chen, SY
    Wang, J
    Yu, GQ
    Liu, WH
    Pearce, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (22) : 14087 - 14092
  • [7] LIPOCORTIN-1 AND THE CONTROL OF ARACHIDONIC-ACID RELEASE IN CELL SIGNALING - GLUCORTICOIDS INHIBIT G-PROTEIN-DEPENDENT ACTIVATION OF CPLA(2) ACTIVITY
    CROXTALL, JD
    CHOUDHURY, Q
    TOKUMOTO, H
    FLOWER, RJ
    [J]. BIOCHEMICAL PHARMACOLOGY, 1995, 50 (04) : 465 - 474
  • [8] Lipocortin 1 and the control of cPLA(2) activity in A549 cells - Glucocorticoids block EGF stimulation of cPLA(2) phosphorylation
    Croxtall, JD
    Choudhury, Q
    Newman, S
    Flower, RJ
    [J]. BIOCHEMICAL PHARMACOLOGY, 1996, 52 (02) : 351 - 356
  • [9] Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells
    Festuccia, C
    Dolo, V
    Guerra, F
    Violini, S
    Muzi, P
    Pavan, A
    Bologna, M
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 1998, 16 (06) : 513 - 528
  • [10] LIPOCORTIN-1 - CELLULAR MECHANISMS AND CLINICAL RELEVANCE
    FLOWER, RJ
    ROTHWELL, NJ
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (03) : 71 - 76